- Home
- GENC vs CATX Comparison
GENC vs CATX Comparison
Compare GENC & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GENC
- CATX
- Stock Information
- Founded
- GENC 1894
- CATX 1983
- Country
- GENC United States
- CATX United States
- Employees
- GENC N/A
- CATX 140
- Industry
- GENC Construction/Ag Equipment/Trucks
- CATX Medical/Dental Instruments
- Sector
- GENC Industrials
- CATX Health Care
- Exchange
- GENC Nasdaq
- CATX Nasdaq
- Market Cap
- GENC 181.9M
- CATX 182.9M
- IPO Year
- GENC N/A
- CATX N/A
- Fundamental
- Price
- GENC $13.12
- CATX $2.42
- Analyst Decision
- GENC
- CATX Strong Buy
- Analyst Count
- GENC 0
- CATX 10
- Target Price
- GENC N/A
- CATX $13.89
- AVG Volume (30 Days)
- GENC 21.9K
- CATX 701.4K
- Earning Date
- GENC 05-16-2025
- CATX 05-12-2025
- Dividend Yield
- GENC N/A
- CATX N/A
- EPS Growth
- GENC 35.02
- CATX N/A
- EPS
- GENC 1.11
- CATX N/A
- Revenue
- GENC $113,116,000.00
- CATX $1,454,000.00
- Revenue This Year
- GENC N/A
- CATX N/A
- Revenue Next Year
- GENC N/A
- CATX N/A
- P/E Ratio
- GENC $11.17
- CATX N/A
- Revenue Growth
- GENC 5.44
- CATX 1.40
- 52 Week Low
- GENC $10.80
- CATX $1.60
- 52 Week High
- GENC $24.88
- CATX $19.10
- Technical
- Relative Strength Index (RSI)
- GENC 58.45
- CATX 54.45
- Support Level
- GENC $12.00
- CATX $2.18
- Resistance Level
- GENC $13.59
- CATX $2.65
- Average True Range (ATR)
- GENC 0.60
- CATX 0.16
- MACD
- GENC 0.14
- CATX 0.03
- Stochastic Oscillator
- GENC 82.06
- CATX 70.25
About GENC Gencor Industries Inc.
Gencor Industries Inc and its subsidiaries is a manufacturer of heavy machinery used in the production of highway construction materials and environmental control equipment. The Company has one reporting segment, equipment for the highway construction industry. The firm's principal products include asphalt plants, combustion systems, hot mix asphalt plants, fluid heat transfer systems, and asphalt pavers.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.